Concepedia

Joseph Wahle

JW

Statistics

Publications

8

Citations

696

H-Index

8

Active since

2006

Affiliations

Moffitt Cancer Center(Current)

Boehringer Ingelheim (United States)

Washington University in St. Louis

University of South Florida

Howard Hughes Medical Institute

Joseph Wahle is an author at Moffitt Cancer Center specializing in life sciences, immunology, and natural killer cell regulation.

Publications per year

2006–2023

8

Publications

8

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients

Koen Venken, Peggy Jacques, Céline Mortier et al. · Nature Communications · 2018 · 310 citations · Full text

, , +17

MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment

Julie M. Elliott, Joseph Wahle, Wayne M. Yokoyama · The Journal of Experimental Medicine · 2010 · 211 citations · Full text

, , +16

Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell

Joseph Wahle, Kim H.T. Paraiso, Robert D. Kendig et al. · The Journal of Immunology · 2007 · 51 citations

, , +17

An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients

Helena Bassolas-Molina, Ernest Raymond, Mark E. Labadia et al. · Frontiers in Immunology · 2018 · 48 citations · Full text

, , +17

Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets

Joseph Wahle, Kim H.T. Paraiso, Amy Costello et al. · The Journal of Immunology · 2006 · 35 citations

, , +14

1–5 of 8